Stem cell therapy may prevent PAD-related amputations

Patients with critical limb ischemia who received injections of stem cells derived from their bone marrow had a lower risk of amputation and death than patients who were not treated with the therapy in a Phase II clinical trial.

View Full Article in:

Stem Cells Improve Outlook for Severe PAD - DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA